PAVmed
PAVM
107 hedge funds and large institutions have $199M invested in PAVmed in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 16 closing their positions.
69% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 16
67% more call options, than puts
Call options by funds: $4.61M | Put options by funds: $2.76M
48% more capital invested
Capital invested by funds: $134M → $199M (+$64.4M)
14% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 28
10% more funds holding
Funds holding: 97 → 107 (+10)
0.01% more ownership
Funds ownership: 0.06% → 0.06% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$10.2M |
| 2 |
Morgan Stanley
New York
|
+$2.61M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
+$1.99M |
| 4 |
Jane Street
New York
|
+$1.98M |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.63M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$1.16M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$484K |
| 4 |
Two Sigma Investments
New York
|
-$466K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$438K |
PAVM Hedge Fund Activity: Q3 2021 in Review
107 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q3 2021, worth a combined $199M — up 48% from $134M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new PAVM positions and 16 closed out — a net gain of 11 holders — while 32 added to existing stakes and 28 trimmed.
The largest buyer was State Street, adding an estimated $10.2M. The largest seller was Nuveen, cutting an estimated $2.63M.
- 107 institutional investors held PAVmed (PAVM) as of Q3 2021, up from 97 in Q2 2021.
- Funds reported $199M of PAVmed stock for Q3 2021, up 48% quarter-over-quarter.
- 27 funds opened new PAVmed positions in Q3 2021 and 16 closed out, a net change of +11 holders.
- The largest PAVmed buyer in Q3 2021 was State Street, an estimated $10.2M added.
- The largest PAVmed seller in Q3 2021 was Nuveen, an estimated $2.63M sold.
Based on aggregated 13F filings for Q3 2021.